Around the Helix: Cell and Gene Therapy Company Updates – May 24, 2023
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Annual ACGT Summit Brings Together Cancer Cell Therapy and Gene Therapy Experts
Alliance for Cancer Gene Therapy (ACGT) recently hosted their 2023 Summit, a scientific gathering of cancer experts to discuss challenges and opportunities with cell and gene therapy.
FDA Approves Epkinly T-Cell Engaging Bispecific Antibody for R/R DLBCL
The approval was based on data from the phase 1/2 EPCORE NHL-1 clinical trial.
Bringing HLA-A*02-directed CAR T to Solid Tumor Care With the EVEREST-1 Trial
Diane M. Simeone, MD, discussed the phase 1/2 EVEREST-1 trial, which seeks to assess the novel CAR T-cell therapy A2B530 in patients with solid tumors—hopefully progressing one-and-done engineered therapies in this population.
Advancing Gene and Cell Therapies for Brain Cancer
May is Brain Cancer Awareness Month, and the ACGT is raising awareness of the potential of the human immune system when combined with cell and gene therapy to defeat brain tumors.
CGTLive’s Weekly Rewind – May 19, 2023
Review top news and interview highlights from the week ending May 12, 2023.
